Bombi Biomics BV is a biotechnology company specializing in the development of eukaryotic cell-free expressed antimicrobials. Headquartered in Eindhoven, the Netherlands, Bombi was founded in January 2021.
Before our company officially launched, nearly a decade of R&D went into what Bombi is today.
The immediate priorities were turning to academia to bring the best skills to the nascent organization and hiring an exceptional team of experts in order to have all of our technologies in place and to make them work in perfect synergy.
Our multi-disciplinary team began to map out a scientific strategy, collaborations and operational plan. Each member brought a unique perspective and skill set to the internal collaboration. Many other colleagues and partners; from business development to human resources to legal to finance – also contributed time and perspective, highlighting the focus on cross-functional collaboration which is the hallmark of our culture.
team of experts
& Chief Science Officer
dr. Sam moré
Chief Medical Officer
Nanomaterials in Medicine
Head of Quality
jos vanden abeele, msc
dr. margret more
Univ.-Prof. Dr. Wolfgang Bäumer